Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0348321 (
Haemophilus
)
15,372
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although
Haemophilus
influenzae requires heme for growth, the source of heme during invasive infections is not known. We compared heme,
lactoperoxidase
, catalase, cytochrome c, myoglobin, and hemoglobin as sources of heme for growth in defined media. The minimum concentration of heme permitting unrestricted growth of strain E1a, an H. influenzae type b isolate from cerebrospinal fluid, was 0.02 micrograms/ml. Using molar equivalents of heme as
lactoperoxidase
, catalase, cytochrome c, myoglobin, and hemoglobin, we determined that myoglobin and hemoglobin permitted unrestricted growth at this concentration. To determine the ability of host defenses to sequester heme from H. influenzae, we used affinity chromatography to purify human haptoglobin and hemopexin, serum proteins which bind hemoglobin and heme. Plate assays revealed that 12 strains of H. influenzae acquired heme from hemoglobin, hemoglobin-haptoglobin, heme-hemopexin, and heme-albumin. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of outer membrane proteins of strain E1a grown in heme-replete and heme-restricted conditions revealed a heme-repressible outer membrane protein with an apparent molecular mass of 38 kilodaltons. These results demonstrated that, unlike Escherichia coli, H. influenzae may acquire heme from hemoglobin-haptoglobin. H. influenzae also may acquire heme from hemopexin and albumin, which have not been previously investigated. The role of outer membrane proteins in the acquisition of heme is not yet clear.
...
PMID:Protein sources of heme for Haemophilus influenzae. 302 98
Outer membrane proteins of
Haemophilus
influenzae type b which are immunogenic in infant rats were identified by a radioimmunoprecipitation method. Intact cells of H. influenzae type b were radioiodinated by a
lactoperoxidase
-catalyzed procedure, and an outer membrane-containing fraction was prepared from these cells. These radioiodinated outer membranes were mixed with sera obtained from rats convalescing from systemic H. influenzae type b disease induced at 6 days of age, and the resultant (antibody-outer membrane protein antigen) complexes were extracted from these membranes by treatment with nonionic detergent and ethylenediaminetetraacetic acid. These soluble antibody-antigen complexes were isolated by means of adsorption to protein A-bearing staphylococci, and the radioiodinated protein antigens were identified by gel electrophoresis followed by autoradiography. Infant rats were shown to mount a readily detectable antibody response to several different proteins present in the outer membrane of H. influenzae type b. Individual infant rats were found to vary both qualitatively and quantitatively in their immune response to these immunogenic outer membrane proteins.
...
PMID:Identification of immunogenic outer membrane proteins of Haemophilus influenzae type b in the infant rat model system. 697 15
The lactoperoxidase (LPO) antibiotic system is a well-characterized component of mammary and salivary gland secretions. Because
LPO
has been shown to function in ovine airways, human airway tissue and secretions were examined for the presence of
LPO
and its substrate, the anion thiocyanate (SCN-). In addition, human airway secretions were tested for
LPO
-mediated antibacterial activity, and
LPO
's activity was assessed against some human airway pathogens. The data showed that normal human airway secretions contained
LPO
enzyme activity (0.65 +/- 0.09 microg/mg secreted protein; n = 17), and Western blots of secretions demonstrated bands of the expected sizes for
LPO
.
LPO
mRNA was detected in trachea by sequencing PCR-amplified cDNA. SCN-,
LPO
's substrate, was present in undiluted airway secretions at concentrations sufficient for
LPO
catalysis (0.46 +/- 0.19 mM; n = 8), and diluted secretions contained antibacterial activity with
LPO
-like properties. Immunocytochemistry localized
LPO
to submucosal glands in human bronchi. Finally, as expected based on the known antibacterial spectrum of the
LPO
system, airway secretions showed
LPO
-dependent activity against Pseudomonas aeruginosa. In addition, the airway
LPO
system was shown to be effective against Burkholderia cepacia and
Haemophilus
influenzae. Thus, a functional
LPO
system exists in human airways and may contribute to airway host defense against infection.
...
PMID:Lactoperoxidase and human airway host defense. 1262 41